<!DOCTYPE html>
<html lang="en">
    <head>
        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        <meta name="robots" content="noodp" />
        <title>有效的治疗性抗体中和SARS-CoV-2和SARS-CoV的结构基础 - Milky板板の博客</title><meta name="Description" content="Milky板板"><meta property="og:title" content="有效的治疗性抗体中和SARS-CoV-2和SARS-CoV的结构基础" />
<meta property="og:description" content="概述： 人源化单克隆抗体H014，通过与S受体结合区域(RBD)结合，在纳米水平上有效中和SARS-CoV-2和SARS-CoV伪病毒以及真实的SARS-CoV-2（RBD处于开放构像才可以）
对可用的抗SARS-CoV和SARS-CoV-2中和抗体的表位分析发现了广泛的交叉保护表位。 H014 Ig G和Fab片段都与两个RBD紧密结合，在SARS-CoV-2 RBD和SARS-CoV RBD的亚nM水平上具有相当的结合亲和力
伪病毒中和试验表明，H014具有强大的中和活性：针对SARS-CoV-2和SARS-CoV假病毒的50％中和浓度值（IC50）分别为3 nM和1 nM。
针对真正的SARS-CoV-2菌株（BetaCoV / Beijing / AMMS01 / 2020）进行的噬斑减少中和测试（PRNT）验证了中和活性，IC50为38 nM，比假分型系统中观察到的低50倍 在先前建立的对SARS-CoV-2感染敏感的人ACE2（hACE2）人源化小鼠模型中评估H014的体内保护功效（15）。 在该模型中，由于hACE2在肺细胞上的表达，SARS-CoV-2进入肺部并与人类疾病一样复制，在感染后5天表现出肺部病理（dpi）。 hACE2-人源化小鼠经鼻腔感染5×105 PFU（1剂，治疗）后4小时（1剂，治疗）或之前12小时和4小时（2剂，预防加治疗）后以50 mg / kg腹膜内注射 SARS-CoV-2（BetaCoV /北京/ AMMS01 / 2020）。 在第5天处死所有受攻击的动物。而在第5天，PBS组（对照）肺中的病毒载量飙升至约107 RNA拷贝/ g。
值得注意的是，在预防组和预防组与治疗组中，H014处理分别在第5天导致肺中病毒滴度降低了约10倍和100倍（图1D）。 肺部病理分析表明，SARS-CoV-2引起轻度间质性肺炎，其特征是在PBS治疗后炎症细胞浸润，肺泡间隔增厚和明显的血管系统损伤。 相反，在接受H014治疗的小鼠的肺切片中未观察到明显的肺泡上皮细胞病变或局灶性出血（图1E），表明H014在治愈COVID-19中具有潜在的治疗作用。
具有H014 Fab片段的复合物中稳定的SARS-CoV-2 Sectodomain的Cryo-EM表征表明，该复合物采用三种不同的构象状态，分别对应于一个RBD打开&#43;两个RBD关闭（状态1），两个RBD打开 &#43;一个已关闭的RBD（状态2）和所有三个已打开的RBD（状态3）
有趣的是，在冷冻EM数据的3D分类期间，即使存在过多的Fab，也观察到了完全封闭的（状态4）SARS-CoV-2 S三聚体的结构，没有任何Fab结合，尽管存在过量的Fab，这表明H014的结合位点 通过蛋白质“呼吸”和随机的RBD运动暴露
asymmetric cryo-EM reconstructions of the 4 states at 3.4 – 3.6 Å
H014 recognizes a conformational epitope on one side of the open RBD, only involving protein/protein contacts, dis- tinct from the receptor-binding motif (RBM)" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://uioqps.github.io/%E6%9C%89%E6%95%88%E7%9A%84%E6%B2%BB%E7%96%97%E6%80%A7%E6%8A%97%E4%BD%93%E4%B8%AD%E5%92%8Csars-cov-2%E5%92%8Csars-cov%E7%9A%84%E7%BB%93%E6%9E%84%E5%9F%BA%E7%A1%80/" /><meta property="og:image" content="https://uioqps.github.io/logo.png"/><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2020-08-31T00:00:00+00:00" />
<meta property="article:modified_time" content="2020-08-31T00:00:00+00:00" /><meta property="og:site_name" content="Milky板板の博客" />

<meta name="twitter:card" content="summary_large_image"/>
<meta name="twitter:image" content="https://uioqps.github.io/logo.png"/>

<meta name="twitter:title" content="有效的治疗性抗体中和SARS-CoV-2和SARS-CoV的结构基础"/>
<meta name="twitter:description" content="概述： 人源化单克隆抗体H014，通过与S受体结合区域(RBD)结合，在纳米水平上有效中和SARS-CoV-2和SARS-CoV伪病毒以及真实的SARS-CoV-2（RBD处于开放构像才可以）
对可用的抗SARS-CoV和SARS-CoV-2中和抗体的表位分析发现了广泛的交叉保护表位。 H014 Ig G和Fab片段都与两个RBD紧密结合，在SARS-CoV-2 RBD和SARS-CoV RBD的亚nM水平上具有相当的结合亲和力
伪病毒中和试验表明，H014具有强大的中和活性：针对SARS-CoV-2和SARS-CoV假病毒的50％中和浓度值（IC50）分别为3 nM和1 nM。
针对真正的SARS-CoV-2菌株（BetaCoV / Beijing / AMMS01 / 2020）进行的噬斑减少中和测试（PRNT）验证了中和活性，IC50为38 nM，比假分型系统中观察到的低50倍 在先前建立的对SARS-CoV-2感染敏感的人ACE2（hACE2）人源化小鼠模型中评估H014的体内保护功效（15）。 在该模型中，由于hACE2在肺细胞上的表达，SARS-CoV-2进入肺部并与人类疾病一样复制，在感染后5天表现出肺部病理（dpi）。 hACE2-人源化小鼠经鼻腔感染5×105 PFU（1剂，治疗）后4小时（1剂，治疗）或之前12小时和4小时（2剂，预防加治疗）后以50 mg / kg腹膜内注射 SARS-CoV-2（BetaCoV /北京/ AMMS01 / 2020）。 在第5天处死所有受攻击的动物。而在第5天，PBS组（对照）肺中的病毒载量飙升至约107 RNA拷贝/ g。
值得注意的是，在预防组和预防组与治疗组中，H014处理分别在第5天导致肺中病毒滴度降低了约10倍和100倍（图1D）。 肺部病理分析表明，SARS-CoV-2引起轻度间质性肺炎，其特征是在PBS治疗后炎症细胞浸润，肺泡间隔增厚和明显的血管系统损伤。 相反，在接受H014治疗的小鼠的肺切片中未观察到明显的肺泡上皮细胞病变或局灶性出血（图1E），表明H014在治愈COVID-19中具有潜在的治疗作用。
具有H014 Fab片段的复合物中稳定的SARS-CoV-2 Sectodomain的Cryo-EM表征表明，该复合物采用三种不同的构象状态，分别对应于一个RBD打开&#43;两个RBD关闭（状态1），两个RBD打开 &#43;一个已关闭的RBD（状态2）和所有三个已打开的RBD（状态3）
有趣的是，在冷冻EM数据的3D分类期间，即使存在过多的Fab，也观察到了完全封闭的（状态4）SARS-CoV-2 S三聚体的结构，没有任何Fab结合，尽管存在过量的Fab，这表明H014的结合位点 通过蛋白质“呼吸”和随机的RBD运动暴露
asymmetric cryo-EM reconstructions of the 4 states at 3.4 – 3.6 Å
H014 recognizes a conformational epitope on one side of the open RBD, only involving protein/protein contacts, dis- tinct from the receptor-binding motif (RBM)"/>
<meta name="application-name" content="Milky板板の博客">
<meta name="apple-mobile-web-app-title" content="Milky板板の博客"><link rel="shortcut icon" type="image/x-icon" href="/favicon.ico" />
        <link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png">
        <link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png"><link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png"><link rel="manifest" href="/site.webmanifest"><link rel="canonical" href="https://uioqps.github.io/%E6%9C%89%E6%95%88%E7%9A%84%E6%B2%BB%E7%96%97%E6%80%A7%E6%8A%97%E4%BD%93%E4%B8%AD%E5%92%8Csars-cov-2%E5%92%8Csars-cov%E7%9A%84%E7%BB%93%E6%9E%84%E5%9F%BA%E7%A1%80/" /><link rel="prev" href="https://uioqps.github.io/crisprcas9-active-system/" /><link rel="next" href="https://uioqps.github.io/%E5%BA%B7%E5%A4%8D%E6%82%A3%E8%80%85b%E7%BB%86%E8%83%9E%E9%AB%98%E9%80%9A%E9%87%8F%E5%8D%95%E7%BB%86%E8%83%9E%E6%B5%8B%E5%BA%8F%E9%89%B4%E5%AE%9A%E7%9A%84%E6%8A%97sars-cov-2%E7%9A%84%E4%B8%AD%E5%92%8C%E6%8A%97%E4%BD%93/" /><link rel="stylesheet" href="/css/style.min.css"><link rel="preload" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.1.1/css/all.min.css" as="style" onload="this.onload=null;this.rel='stylesheet'">
        <noscript><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.1.1/css/all.min.css"></noscript><link rel="preload" href="https://cdn.jsdelivr.net/npm/animate.css@4.1.1/animate.min.css" as="style" onload="this.onload=null;this.rel='stylesheet'">
        <noscript><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/animate.css@4.1.1/animate.min.css"></noscript><script type="application/ld+json">
    {
        "@context": "http://schema.org",
        "@type": "BlogPosting",
        "headline": "有效的治疗性抗体中和SARS-CoV-2和SARS-CoV的结构基础",
        "inLanguage": "en",
        "mainEntityOfPage": {
            "@type": "WebPage",
            "@id": "https:\/\/uioqps.github.io\/%E6%9C%89%E6%95%88%E7%9A%84%E6%B2%BB%E7%96%97%E6%80%A7%E6%8A%97%E4%BD%93%E4%B8%AD%E5%92%8Csars-cov-2%E5%92%8Csars-cov%E7%9A%84%E7%BB%93%E6%9E%84%E5%9F%BA%E7%A1%80\/"
        },"image": [{
                            "@type": "ImageObject",
                            "url": "https:\/\/uioqps.github.io\/images\/Apple-Devices-Preview.png",
                            "width":  3200 ,
                            "height":  2048 
                        }],"genre": "posts","keywords": "SARS-Cov-2, antibody","wordcount":  223 ,
        "url": "https:\/\/uioqps.github.io\/%E6%9C%89%E6%95%88%E7%9A%84%E6%B2%BB%E7%96%97%E6%80%A7%E6%8A%97%E4%BD%93%E4%B8%AD%E5%92%8Csars-cov-2%E5%92%8Csars-cov%E7%9A%84%E7%BB%93%E6%9E%84%E5%9F%BA%E7%A1%80\/","datePublished": "2020-08-31T00:00:00+00:00","dateModified": "2020-08-31T00:00:00+00:00","license": "This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.","publisher": {
            "@type": "Organization",
            "name": "xxxx","logo": {
                    "@type": "ImageObject",
                    "url": "https:\/\/uioqps.github.io\/images\/avatar.png",
                    "width":  588 ,
                    "height":  614 
                }},"author": {
                "@type": "Person",
                "name": "Milky"
            },"description": ""
    }
    </script></head>
    <body data-header-desktop="fixed" data-header-mobile="auto"><script type="text/javascript">(window.localStorage && localStorage.getItem('theme') ? localStorage.getItem('theme') === 'dark' : ('auto' === 'auto' ? window.matchMedia('(prefers-color-scheme: dark)').matches : 'auto' === 'dark')) && document.body.setAttribute('theme', 'dark');</script>

        <div id="mask"></div><div class="wrapper"><header class="desktop" id="header-desktop">
    <div class="header-wrapper">
        <div class="header-title">
            <a href="/" title="Milky板板の博客"><span class="header-title-pre"><i class='fa-sharp fa-light fa-dolphin' aria-hidden='true'></i></span>Milky板板の博客</a>
        </div>
        <div class="menu">
            <div class="menu-inner"><a class="menu-item" href="/posts/"> Posts </a><a class="menu-item" href="/tags/"> Tags </a><a class="menu-item" href="/categories/"> Categories </a><a class="menu-item" href="/categories/documentation/"> Docs </a><a class="menu-item" href="/about/"> About </a><a class="menu-item" href="https://github.com/uioQPS/" title="GitHub" rel="noopener noreffer" target="_blank"><i class='fab fa-github fa-fw' aria-hidden='true'></i>  </a><span class="menu-item delimiter"></span><span class="menu-item search" id="search-desktop">
                        <input type="text" placeholder="Search titles or contents..." id="search-input-desktop">
                        <a href="javascript:void(0);" class="search-button search-toggle" id="search-toggle-desktop" title="Search">
                            <i class="fas fa-search fa-fw" aria-hidden="true"></i>
                        </a>
                        <a href="javascript:void(0);" class="search-button search-clear" id="search-clear-desktop" title="Clear">
                            <i class="fas fa-times-circle fa-fw" aria-hidden="true"></i>
                        </a>
                        <span class="search-button search-loading" id="search-loading-desktop">
                            <i class="fas fa-spinner fa-fw fa-spin" aria-hidden="true"></i>
                        </span>
                    </span><a href="javascript:void(0);" class="menu-item theme-switch" title="Switch Theme">
                    <i class="fas fa-adjust fa-fw" aria-hidden="true"></i>
                </a></div>
        </div>
    </div>
</header><header class="mobile" id="header-mobile">
    <div class="header-container">
        <div class="header-wrapper">
            <div class="header-title">
                <a href="/" title="Milky板板の博客"><span class="header-title-pre"><i class='fa-sharp fa-light fa-dolphin' aria-hidden='true'></i></span>Milky板板の博客</a>
            </div>
            <div class="menu-toggle" id="menu-toggle-mobile">
                <span></span><span></span><span></span>
            </div>
        </div>
        <div class="menu" id="menu-mobile"><div class="search-wrapper">
                    <div class="search mobile" id="search-mobile">
                        <input type="text" placeholder="Search titles or contents..." id="search-input-mobile">
                        <a href="javascript:void(0);" class="search-button search-toggle" id="search-toggle-mobile" title="Search">
                            <i class="fas fa-search fa-fw" aria-hidden="true"></i>
                        </a>
                        <a href="javascript:void(0);" class="search-button search-clear" id="search-clear-mobile" title="Clear">
                            <i class="fas fa-times-circle fa-fw" aria-hidden="true"></i>
                        </a>
                        <span class="search-button search-loading" id="search-loading-mobile">
                            <i class="fas fa-spinner fa-fw fa-spin" aria-hidden="true"></i>
                        </span>
                    </div>
                    <a href="javascript:void(0);" class="search-cancel" id="search-cancel-mobile">
                        Cancel
                    </a>
                </div><a class="menu-item" href="/posts/" title="">Posts</a><a class="menu-item" href="/tags/" title="">Tags</a><a class="menu-item" href="/categories/" title="">Categories</a><a class="menu-item" href="/categories/documentation/" title="">Docs</a><a class="menu-item" href="/about/" title="">About</a><a class="menu-item" href="https://github.com/uioQPS/" title="GitHub" rel="noopener noreffer" target="_blank"><i class='fab fa-github fa-fw' aria-hidden='true'></i></a><a href="javascript:void(0);" class="menu-item theme-switch" title="Switch Theme">
                <i class="fas fa-adjust fa-fw" aria-hidden="true"></i>
            </a></div>
    </div>
</header><div class="search-dropdown desktop">
        <div id="search-dropdown-desktop"></div>
    </div>
    <div class="search-dropdown mobile">
        <div id="search-dropdown-mobile"></div>
    </div><main class="main">
                <div class="container"><div class="toc" id="toc-auto">
            <h2 class="toc-title">Contents</h2>
            <div class="toc-content" id="toc-content-auto"></div>
        </div><article class="page single"><h1 class="single-title animate__animated animate__flipInX">有效的治疗性抗体中和SARS-CoV-2和SARS-CoV的结构基础</h1><div class="post-meta">
            <div class="post-meta-line"><span class="post-author"><a href="https://github.com/uioQPS/" title="Author" target="_blank" rel="noopener noreffer author" class="author"><i class="fas fa-user-circle fa-fw" aria-hidden="true"></i>Milky</a></span>&nbsp;<span class="post-category">included in <a href="/categories/virus/"><i class="far fa-folder fa-fw" aria-hidden="true"></i>virus</a>&nbsp;<a href="/categories/ngs/"><i class="far fa-folder fa-fw" aria-hidden="true"></i>ngs</a></span></div>
            <div class="post-meta-line"><i class="far fa-calendar-alt fa-fw" aria-hidden="true"></i>&nbsp;<time datetime="2020-08-31">2020-08-31</time>&nbsp;<i class="fas fa-pencil-alt fa-fw" aria-hidden="true"></i>&nbsp;223 words&nbsp;
                <i class="far fa-clock fa-fw" aria-hidden="true"></i>&nbsp;2 minutes&nbsp;<span id="/%E6%9C%89%E6%95%88%E7%9A%84%E6%B2%BB%E7%96%97%E6%80%A7%E6%8A%97%E4%BD%93%E4%B8%AD%E5%92%8Csars-cov-2%E5%92%8Csars-cov%E7%9A%84%E7%BB%93%E6%9E%84%E5%9F%BA%E7%A1%80/" class="leancloud_visitors" data-flag-title="有效的治疗性抗体中和SARS-CoV-2和SARS-CoV的结构基础">
                        <i class="far fa-eye fa-fw" aria-hidden="true"></i>&nbsp;<span class=leancloud-visitors-count></span>&nbsp;views
                    </span>&nbsp;</div>
        </div><div class="details toc" id="toc-static"  data-kept="">
                <div class="details-summary toc-title">
                    <span>Contents</span>
                    <span><i class="details-icon fas fa-angle-right" aria-hidden="true"></i></span>
                </div>
                <div class="details-content toc-content" id="toc-content-static"><nav id="TableOfContents">
  <ul>
    <li>
      <ul>
        <li><a href="#概述">概述：</a></li>
        <li><a href="#conclusion">conclusion</a></li>
      </ul>
    </li>
  </ul>
</nav></div>
            </div><div class="content" id="content"><h3 id="概述">概述：</h3>
<p>人源化单克隆抗体H014，通过与S受体结合区域(RBD)结合，在纳米水平上有效中和SARS-CoV-2和SARS-CoV伪病毒以及真实的SARS-CoV-2（RBD处于开放构像才可以）</p>
<p>对可用的抗SARS-CoV和SARS-CoV-2中和抗体的表位分析发现了广泛的交叉保护表位。
<img
        class="lazyload"
        src="/svg/loading.min.svg"
        data-src="download.png"
        data-srcset="download.png, download.png 1.5x, download.png 2x"
        data-sizes="auto"
        alt="download.png"
        title="download.png" /></p>
<p>H014 Ig G和Fab片段都与两个RBD紧密结合，在SARS-CoV-2 RBD和SARS-CoV RBD的亚nM水平上具有相当的结合亲和力</p>
<p>伪病毒中和试验表明，H014具有强大的中和活性：针对SARS-CoV-2和SARS-CoV假病毒的50％中和浓度值（IC50）分别为3 nM和1 nM。</p>
<p><img
        class="lazyload"
        src="/svg/loading.min.svg"
        data-src="download-1.png"
        data-srcset="download-1.png, download-1.png 1.5x, download-1.png 2x"
        data-sizes="auto"
        alt="download-1.png"
        title="download-1.png" /></p>
<p>针对真正的SARS-CoV-2菌株（BetaCoV / Beijing / AMMS01 / 2020）进行的噬斑减少中和测试（PRNT）验证了中和活性，IC50为38 nM，比假分型系统中观察到的低50倍
在先前建立的对SARS-CoV-2感染敏感的人ACE2（hACE2）人源化小鼠模型中评估H014的体内保护功效（15）。 在该模型中，由于hACE2在肺细胞上的表达，SARS-CoV-2进入肺部并与人类疾病一样复制，在感染后5天表现出肺部病理（dpi）。 hACE2-人源化小鼠经鼻腔感染5×105 PFU（1剂，治疗）后4小时（1剂，治疗）或之前12小时和4小时（2剂，预防加治疗）后以50 mg / kg腹膜内注射 SARS-CoV-2（BetaCoV /北京/ AMMS01 / 2020）。 在第5天处死所有受攻击的动物。而在第5天，PBS组（对照）肺中的病毒载量飙升至约107 RNA拷贝/ g。</p>
<p><img
        class="lazyload"
        src="/svg/loading.min.svg"
        data-src="download-2.png"
        data-srcset="download-2.png, download-2.png 1.5x, download-2.png 2x"
        data-sizes="auto"
        alt="download-2.png"
        title="download-2.png" />
值得注意的是，在预防组和预防组与治疗组中，H014处理分别在第5天导致肺中病毒滴度降低了约10倍和100倍（图1D）。 肺部病理分析表明，SARS-CoV-2引起轻度间质性肺炎，其特征是在PBS治疗后炎症细胞浸润，肺泡间隔增厚和明显的血管系统损伤。 相反，在接受H014治疗的小鼠的肺切片中未观察到明显的肺泡上皮细胞病变或局灶性出血（图1E），表明H014在治愈COVID-19中具有潜在的治疗作用。</p>
<p><img
        class="lazyload"
        src="/svg/loading.min.svg"
        data-src="download-3.png"
        data-srcset="download-3.png, download-3.png 1.5x, download-3.png 2x"
        data-sizes="auto"
        alt="download-3.png"
        title="download-3.png" />
具有H014 Fab片段的复合物中稳定的SARS-CoV-2 Sectodomain的Cryo-EM表征表明，该复合物采用三种不同的构象状态，分别对应于一个RBD打开+两个RBD关闭（状态1），两个RBD打开 +一个已关闭的RBD（状态2）和所有三个已打开的RBD（状态3）</p>
<p>有趣的是，在冷冻EM数据的3D分类期间，即使存在过多的Fab，也观察到了完全封闭的（状态4）SARS-CoV-2 S三聚体的结构，没有任何Fab结合，尽管存在过量的Fab，这表明H014的结合位点 通过蛋白质“呼吸”和随机的RBD运动暴露</p>
<p>asymmetric cryo-EM reconstructions of the 4 states at 3.4 – 3.6 Å</p>
<p><img
        class="lazyload"
        src="/svg/loading.min.svg"
        data-src="download-4.png"
        data-srcset="download-4.png, download-4.png 1.5x, download-4.png 2x"
        data-sizes="auto"
        alt="download-4.png"
        title="download-4.png" /></p>
<p>H014 recognizes a conformational epitope on one side of the open RBD, only involving protein/protein contacts, dis- tinct from the receptor-binding motif (RBM)</p>
<p>H014互补位构成了所有六个互补决定区（CDR）环（CDRL1-3和CDRH1-3）和异常的重链框架（HF-R，残基58-65），它们与RBD形成紧密的相互作用，从而导致 在约1,000Å2的掩埋区域</p>
<p>轻链和重链的可变域通过疏水和亲水接触分别占埋藏表面积的32％和68％。 H014表位由21个残基组成，主要位于α2-β2-η2（残基368-386），η3（残基405-408、411-413），α4（残基439）和η4（残基503）区域， 它们在RBD的一侧构造了一个空腔（图2，B和D，以及图S7）。 12个残基的长CDRH3插入该腔中，富集疏水残基（YDPYYVM）的CDRH3接触RBD的五链β-折叠（β2）区域的η3和边缘（fig.2D）</p>
<p>RBD与H014之间的紧密结合主要归因于两个补丁的广泛疏水相互作用：一个由CDRH2的F54，来自CDRH3和A411的Y101，RBD的P412和Y508形成，另一个由Y49 from CDRL2,  P103, Y104, Y105 from CDRH3 and  V407, V503 and Y508 of the RBD （fig.2E）</p>
<p>此外，CDRH1和HF-R的亲水性接触进一步增强了RBD-H014的相互作用，从而在25°C或37°C的温度下，在亚nM水平上具有极高的结合亲和力 (fig.2E)</p>
<p><img
        class="lazyload"
        src="/svg/loading.min.svg"
        data-src="download-5.png"
        data-srcset="download-5.png, download-5.png 1.5x, download-5.png 2x"
        data-sizes="auto"
        alt="download-5.png"
        title="download-5.png" /></p>
<p>为了研究H014是否会干扰SARS-CoV-2或SARS-CoV的RBD与ACE2的结合，我们在蛋白质和细胞水平上进行了竞争性结合测定。 酶联免疫吸附试验（ELISA）表明，H014能够与重组ACE2竞争结合SARS-CoV-2和SARS-CoV的RBD，EC50值分别为0.7 nM和5 nM。</p>
<p>此外，H014有效地阻止了SARS-CoV-2 RBD与表达ACE2的293T细胞的结合以及重组ACE2与SARS-CoV-2 S的表达293T细胞的结合（图3B）。为了验证其在三聚体S上的潜在完全闭塞，我们通过将三聚体S首先暴露于H014，然后暴露于ACE2或相反的方式，进行了两组表面等离振子共振（SPR）分析。如预期的那样，H014的结合完全阻止了ACE2与三聚体S的结合。此外，ACE2可能会从三聚体S置换并被H014取代（图3C）。为了在基于细胞的病毒感染模型中进一步验证这些结果，进行了实时RT-PCR分析以量化残留在宿主细胞表面的病毒数量，这些病毒暴露于病毒在病毒附着之前或之后附着在细胞上在4°C下。 H014以剂量依赖的方式有效地防止了SARS-CoV-2附着在细胞表面，已经结合到细胞表面的病毒颗粒可能会被H014部分剥离（图3D）。</p>
<p><img
        class="lazyload"
        src="/svg/loading.min.svg"
        data-src="download-6.png"
        data-srcset="download-6.png, download-6.png 1.5x, download-6.png 2x"
        data-sizes="auto"
        alt="download-6.png"
        title="download-6.png" /></p>
<p>H014-SARS-CoV-2三聚体S复合物的结构在ACE2-SARS-CoV-2 RBD复合物结构上的叠加显示ACE2和H014之间存在冲突，这是由于属于结合位点的区域重叠造成的在RBD的顶螺旋（η4）处（图3E）。该观察结果与大多数已知的SARS RBD靶向抗体复合物完全不同，在后者中，抗体直接识别RBM（22-25）。因此，H014阻止SARS-CoV-2附着于宿主细胞的能力可以归因于与ACE2的空间冲突。与RBM相似，H014表位仅在开放状态下可访问，表明其作用类似于HBM。 RBM –在与宿主细胞相互作用中涉及动态干扰。我们的结构与先前报道的冠状病毒S结构（不包括人类冠状病毒HKU1（20））一起观察到了S1亚基的呼吸，它介导了“封闭”和“开放”构象之间的过渡。</p>
<p>In contrast to the hinge-like movement of the RBD observed in most structures, the conformational transi- tion from “close” to “open” observed in our structures mainly involves two steps of rotations: 1) counterclockwise move- ment of SD1 by ~25° encircling the hinge point (at residue 320); 2) the RBD rotates itself counterclockwise by ~60°</p>
<p>These conformational rotations of the SD1 and RBD at proximal points relay an amplified alteration at the distal end, leading to opening up of adequate space for the binding of H014 or ACE2</p>
<p>模棱两可的是，在我们复杂的结构中观察到的特殊构象转变是由于H014的参与或SD1和RBD的协同运动导致的。</p>
<p><img
        class="lazyload"
        src="/svg/loading.min.svg"
        data-src="download-7.png"
        data-srcset="download-7.png, download-7.png 1.5x, download-7.png 2x"
        data-sizes="auto"
        alt="download-7.png"
        title="download-7.png" />
体液免疫对于预防冠状病毒感染是必不可少的，并且已证明消炎血浆的被动免疫可有效治疗SARS和COVID-19（12，26）。先前已经报道了许多SARS-CoV特异性中和抗体，包括m396、80R和F26G19，它们主要与RBM核心（SARS-CoV中的残基484-492）结合，只要RBD处于开放构象即可（图4，C和D）（24、27、28）。出乎意料的是，到目前为止，这些抗体均未显示出抗SARS-CoV-2的令人印象深刻的中和活性（7，8）。 S230是一种SARS-CoV中和抗体，尽管也需要RBD处于打开状态，但它在功能上模仿受体附着并促进膜融合，它可识别RBM顶部的小斑块（图4，C和D）（17 ）。最近，2003年来自SARS幸存者记忆B细胞的另外两种抗体（CR3022和S309）表现出与SARS-CoV-2的强结合力（9、10）。出人意料的是，CR3022无法在体外中和SARS-CoV-2，这可能是由于CR3022结合了一个隐秘的抗原决定簇，该抗原决定簇位于RBD的远端，并且仅当至少两个RBD处于打开状态时才可访问。此外，CR3022不与ACE2竞争与RBD的结合</p>
<h3 id="conclusion">conclusion</h3>
<p>相比之下，最近报道的针对SARS-CoV和SARS-CoV-2的中和mAb S309识别了在SARS-CoV和SARS-CoV-2 RBD的打开和关闭状态均可访问的保守的含聚糖表位（ 10）。 S309的中和机制不依赖于受体结合的直接阻断，而是诱导抗体依赖性细胞的细胞毒性（ADCC）和抗体依赖性细胞的吞噬作用（ADCP）。 我们报道了一种有效的治疗性抗体H014，它可以通过阻断病毒与宿主细胞的附着来交叉中和SARS-CoV-2和SARS-CoV感染（图3）。 与其他抗体不同，H014结合RBD的一个完整侧面，从近端η2到RBM的远端边缘，并具有与SARS-CoV特异性抗体（例如m392、80R，F26G19，CR3022和S309）部分重叠的表位（图。 4，C和D）。</p>
<p>三种交叉反应抗体（CR3022，S309和H014）识别位于RBM以外的更多保守表位，其中CR3022表位与RBM距离最远（图4，C和D），提示其无法进行 中和SARS-CoV-2。 H014结合更保守的表位，其中一些与RBM非常接近，使其在交叉中和谱系B病毒中有效。 另外，识别超出RBM的更保守补丁的抗体将与靶向RBM的抗体具有协同作用，以增强中和活性，这可以减轻病毒逃逸的风险。 这项研究中揭示的H014表位的分子特征有助于在谱系B内发现广泛的交叉中和表位，并为基于结构的合理疫苗设计提出了有趣的目标。 我们的研究还强调了基于抗体的治疗性干预对COVID-19的治疗前景。</p>
</div><div class="post-footer" id="post-footer">
    <div class="post-info">
        <div class="post-info-line">
            <div class="post-info-mod">
                <span>Updated on 2020-08-31</span>
            </div></div>
        <div class="post-info-line">
            <div class="post-info-md"><span>
                            <a class="link-to-markdown" href="/%E6%9C%89%E6%95%88%E7%9A%84%E6%B2%BB%E7%96%97%E6%80%A7%E6%8A%97%E4%BD%93%E4%B8%AD%E5%92%8Csars-cov-2%E5%92%8Csars-cov%E7%9A%84%E7%BB%93%E6%9E%84%E5%9F%BA%E7%A1%80/index.md" target="_blank">Read Markdown</a>
                        </span></div>
            <div class="post-info-share">
                <span><a href="javascript:void(0);" title="Share on Twitter" data-sharer="twitter" data-url="https://uioqps.github.io/%E6%9C%89%E6%95%88%E7%9A%84%E6%B2%BB%E7%96%97%E6%80%A7%E6%8A%97%E4%BD%93%E4%B8%AD%E5%92%8Csars-cov-2%E5%92%8Csars-cov%E7%9A%84%E7%BB%93%E6%9E%84%E5%9F%BA%E7%A1%80/" data-title="有效的治疗性抗体中和SARS-CoV-2和SARS-CoV的结构基础" data-hashtags="SARS-Cov-2,antibody"><i class="fab fa-twitter fa-fw" aria-hidden="true"></i></a><a href="javascript:void(0);" title="Share on Facebook" data-sharer="facebook" data-url="https://uioqps.github.io/%E6%9C%89%E6%95%88%E7%9A%84%E6%B2%BB%E7%96%97%E6%80%A7%E6%8A%97%E4%BD%93%E4%B8%AD%E5%92%8Csars-cov-2%E5%92%8Csars-cov%E7%9A%84%E7%BB%93%E6%9E%84%E5%9F%BA%E7%A1%80/" data-hashtag="SARS-Cov-2"><i class="fab fa-facebook-square fa-fw" aria-hidden="true"></i></a><a href="javascript:void(0);" title="Share on Hacker News" data-sharer="hackernews" data-url="https://uioqps.github.io/%E6%9C%89%E6%95%88%E7%9A%84%E6%B2%BB%E7%96%97%E6%80%A7%E6%8A%97%E4%BD%93%E4%B8%AD%E5%92%8Csars-cov-2%E5%92%8Csars-cov%E7%9A%84%E7%BB%93%E6%9E%84%E5%9F%BA%E7%A1%80/" data-title="有效的治疗性抗体中和SARS-CoV-2和SARS-CoV的结构基础"><i class="fab fa-hacker-news fa-fw" aria-hidden="true"></i></a><a href="javascript:void(0);" title="Share on Line" data-sharer="line" data-url="https://uioqps.github.io/%E6%9C%89%E6%95%88%E7%9A%84%E6%B2%BB%E7%96%97%E6%80%A7%E6%8A%97%E4%BD%93%E4%B8%AD%E5%92%8Csars-cov-2%E5%92%8Csars-cov%E7%9A%84%E7%BB%93%E6%9E%84%E5%9F%BA%E7%A1%80/" data-title="有效的治疗性抗体中和SARS-CoV-2和SARS-CoV的结构基础"><i data-svg-src="https://cdn.jsdelivr.net/npm/simple-icons@7.3.0/icons/line.svg" aria-hidden="true"></i></a><a href="javascript:void(0);" title="Share on 微博" data-sharer="weibo" data-url="https://uioqps.github.io/%E6%9C%89%E6%95%88%E7%9A%84%E6%B2%BB%E7%96%97%E6%80%A7%E6%8A%97%E4%BD%93%E4%B8%AD%E5%92%8Csars-cov-2%E5%92%8Csars-cov%E7%9A%84%E7%BB%93%E6%9E%84%E5%9F%BA%E7%A1%80/" data-title="有效的治疗性抗体中和SARS-CoV-2和SARS-CoV的结构基础"><i class="fab fa-weibo fa-fw" aria-hidden="true"></i></a></span>
            </div>
        </div>
    </div>

    <div class="post-info-more">
        <section class="post-tags"><i class="fas fa-tags fa-fw" aria-hidden="true"></i>&nbsp;<a href="/tags/sars-cov-2/">SARS-Cov-2</a>,&nbsp;<a href="/tags/antibody/">antibody</a></section>
        <section>
            <span><a href="javascript:void(0);" onclick="window.history.back();">Back</a></span>&nbsp;|&nbsp;<span><a href="/">Home</a></span>
        </section>
    </div>

    <div class="post-nav"><a href="/crisprcas9-active-system/" class="prev" rel="prev" title="CrisprCas9 active system"><i class="fas fa-angle-left fa-fw" aria-hidden="true"></i>CrisprCas9 active system</a>
            <a href="/%E5%BA%B7%E5%A4%8D%E6%82%A3%E8%80%85b%E7%BB%86%E8%83%9E%E9%AB%98%E9%80%9A%E9%87%8F%E5%8D%95%E7%BB%86%E8%83%9E%E6%B5%8B%E5%BA%8F%E9%89%B4%E5%AE%9A%E7%9A%84%E6%8A%97sars-cov-2%E7%9A%84%E4%B8%AD%E5%92%8C%E6%8A%97%E4%BD%93/" class="next" rel="next" title="康复患者B细胞高通量单细胞测序鉴定的抗SARS-CoV-2的中和抗体">康复患者B细胞高通量单细胞测序鉴定的抗SARS-CoV-2的中和抗体<i class="fas fa-angle-right fa-fw" aria-hidden="true"></i></a></div>
</div>
<div id="comments"><div id="valine" class="comment"></div><noscript>
                Please enable JavaScript to view the comments powered by <a href="https://valine.js.org/">Valine</a>.
            </noscript></div></article></div>
            </main><footer class="footer">
        <div class="footer-container"><div class="footer-line" itemscope itemtype="http://schema.org/CreativeWork"><i class="far fa-copyright fa-fw" aria-hidden="true"></i><span itemprop="copyrightYear">2023 - 2024</span><span class="author" itemprop="copyrightHolder">&nbsp;<a href="https://github.com/uioQPS/" target="_blank">Milky</a></span>&nbsp;|&nbsp;<span class="license"><a rel="license external nofollow noopener noreffer" href="https://creativecommons.org/licenses/by-nc/4.0/" target="_blank">CC BY-NC 4.0</a></span></div>
        </div>
    </footer></div>

        <div id="fixed-buttons"><a href="#" id="back-to-top" class="fixed-button" title="Back to Top">
                <i class="fas fa-arrow-up fa-fw" aria-hidden="true"></i>
            </a><a href="#" id="view-comments" class="fixed-button" title="View Comments">
                <i class="fas fa-comment fa-fw" aria-hidden="true"></i>
            </a>
        </div><link rel="stylesheet" href="/lib/valine/valine.min.css"><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/valine@1.5.0/dist/Valine.min.js"></script><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/autocomplete.js@0.38.1/dist/autocomplete.min.js"></script><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/lunr@2.3.9/lunr.min.js"></script><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/lazysizes@5.3.2/lazysizes.min.js"></script><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/clipboard@2.0.11/dist/clipboard.min.js"></script><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/sharer.js@0.5.1/sharer.min.js"></script><script type="text/javascript">window.config={"code":{"copyTitle":"Copy to clipboard","maxShownLines":50},"comment":{"valine":{"appId":"QGzwQXOqs5JOhN4RGPOkR2mR-MdYXbMMI","appKey":"WBmoGyJtbqUswvfLh6L8iEBr","avatar":"mp","el":"#valine","emojiCDN":"https://cdn.jsdelivr.net/npm/emoji-datasource-google@14.0.0/img/google/64/","emojiMaps":{"100":"1f4af.png","alien":"1f47d.png","anger":"1f4a2.png","angry":"1f620.png","anguished":"1f627.png","astonished":"1f632.png","black_heart":"1f5a4.png","blue_heart":"1f499.png","blush":"1f60a.png","bomb":"1f4a3.png","boom":"1f4a5.png","broken_heart":"1f494.png","brown_heart":"1f90e.png","clown_face":"1f921.png","cold_face":"1f976.png","cold_sweat":"1f630.png","confounded":"1f616.png","confused":"1f615.png","cry":"1f622.png","crying_cat_face":"1f63f.png","cupid":"1f498.png","dash":"1f4a8.png","disappointed":"1f61e.png","disappointed_relieved":"1f625.png","dizzy":"1f4ab.png","dizzy_face":"1f635.png","drooling_face":"1f924.png","exploding_head":"1f92f.png","expressionless":"1f611.png","face_vomiting":"1f92e.png","face_with_cowboy_hat":"1f920.png","face_with_hand_over_mouth":"1f92d.png","face_with_head_bandage":"1f915.png","face_with_monocle":"1f9d0.png","face_with_raised_eyebrow":"1f928.png","face_with_rolling_eyes":"1f644.png","face_with_symbols_on_mouth":"1f92c.png","face_with_thermometer":"1f912.png","fearful":"1f628.png","flushed":"1f633.png","frowning":"1f626.png","ghost":"1f47b.png","gift_heart":"1f49d.png","green_heart":"1f49a.png","grimacing":"1f62c.png","grin":"1f601.png","grinning":"1f600.png","hankey":"1f4a9.png","hear_no_evil":"1f649.png","heart":"2764-fe0f.png","heart_decoration":"1f49f.png","heart_eyes":"1f60d.png","heart_eyes_cat":"1f63b.png","heartbeat":"1f493.png","heartpulse":"1f497.png","heavy_heart_exclamation_mark_ornament":"2763-fe0f.png","hole":"1f573-fe0f.png","hot_face":"1f975.png","hugging_face":"1f917.png","hushed":"1f62f.png","imp":"1f47f.png","innocent":"1f607.png","japanese_goblin":"1f47a.png","japanese_ogre":"1f479.png","joy":"1f602.png","joy_cat":"1f639.png","kiss":"1f48b.png","kissing":"1f617.png","kissing_cat":"1f63d.png","kissing_closed_eyes":"1f61a.png","kissing_heart":"1f618.png","kissing_smiling_eyes":"1f619.png","laughing":"1f606.png","left_speech_bubble":"1f5e8-fe0f.png","love_letter":"1f48c.png","lying_face":"1f925.png","mask":"1f637.png","money_mouth_face":"1f911.png","nauseated_face":"1f922.png","nerd_face":"1f913.png","neutral_face":"1f610.png","no_mouth":"1f636.png","open_mouth":"1f62e.png","orange_heart":"1f9e1.png","partying_face":"1f973.png","pensive":"1f614.png","persevere":"1f623.png","pleading_face":"1f97a.png","pouting_cat":"1f63e.png","purple_heart":"1f49c.png","rage":"1f621.png","relaxed":"263a-fe0f.png","relieved":"1f60c.png","revolving_hearts":"1f49e.png","right_anger_bubble":"1f5ef-fe0f.png","robot_face":"1f916.png","rolling_on_the_floor_laughing":"1f923.png","scream":"1f631.png","scream_cat":"1f640.png","see_no_evil":"1f648.png","shushing_face":"1f92b.png","skull":"1f480.png","skull_and_crossbones":"2620-fe0f.png","sleeping":"1f634.png","sleepy":"1f62a.png","slightly_frowning_face":"1f641.png","slightly_smiling_face":"1f642.png","smile":"1f604.png","smile_cat":"1f638.png","smiley":"1f603.png","smiley_cat":"1f63a.png","smiling_face_with_3_hearts":"1f970.png","smiling_imp":"1f608.png","smirk":"1f60f.png","smirk_cat":"1f63c.png","sneezing_face":"1f927.png","sob":"1f62d.png","space_invader":"1f47e.png","sparkling_heart":"1f496.png","speak_no_evil":"1f64a.png","speech_balloon":"1f4ac.png","star-struck":"1f929.png","stuck_out_tongue":"1f61b.png","stuck_out_tongue_closed_eyes":"1f61d.png","stuck_out_tongue_winking_eye":"1f61c.png","sunglasses":"1f60e.png","sweat":"1f613.png","sweat_drops":"1f4a6.png","sweat_smile":"1f605.png","thinking_face":"1f914.png","thought_balloon":"1f4ad.png","tired_face":"1f62b.png","triumph":"1f624.png","two_hearts":"1f495.png","unamused":"1f612.png","upside_down_face":"1f643.png","weary":"1f629.png","white_frowning_face":"2639-fe0f.png","white_heart":"1f90d.png","wink":"1f609.png","woozy_face":"1f974.png","worried":"1f61f.png","yawning_face":"1f971.png","yellow_heart":"1f49b.png","yum":"1f60b.png","zany_face":"1f92a.png","zipper_mouth_face":"1f910.png","zzz":"1f4a4.png"},"enableQQ":false,"highlight":true,"lang":"en","pageSize":10,"placeholder":"Your comment ...","recordIP":true,"serverURLs":"https://leancloud.hugoloveit.com","visitor":true}},"search":{"highlightTag":"em","lunrIndexURL":"/index.json","maxResultLength":10,"noResultsFound":"No results found","snippetLength":30,"type":"lunr"}};</script><script type="text/javascript" src="/js/theme.min.js"></script></body>
</html>
